Status:
COMPLETED
Prospective Follow-up of a Cohort of Pre-diabetics in the North of France (DiabeNord)
Lead Sponsor:
Nantes University Hospital
Conditions:
Prediabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to identify in prediabetic subjects, physiopathological changes involved in the evolution to type 2 diabetes mellitus and to identify new biomarkers of type 2 diabetes ris...
Detailed Description
Type 2 diabetes (T2D) is a real public health issue, with an exponential incidence. Before its diagnosis, several physiopathological changes are already taking place, such as insulin resistance of tar...
Eligibility Criteria
Inclusion
- Previous history (within 2 months prior to enrollment visit) of fasting blood glucose ≥ 1,10 g/l and \< 1,26 g/l OR fasting blood glucose ≥ 1 g/l and \< 1,10 g/l with HbA1c ≥ 6,5%.
Exclusion
- Fasting glycemia ≥ 1.26 g/l
- History of treatment with oral antidiabetics
- History of treatment with insulin, except gestational diabetes
- Subject with any history or presence of significant hematologic (coagulation, thrombopenia, …), hepatic, renal, or psychiatric disorders
- Subject unable to follow the study during the 5 years of follow-up
- Subject in exclusion period of a previous study or simultaneously participating to any other clinical trial on metabolism
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 23 2017
Estimated Enrollment :
207 Patients enrolled
Trial Details
Trial ID
NCT01432509
Start Date
September 1 2011
End Date
November 23 2017
Last Update
April 6 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Nutrition Center Naturalpha (CNCN)
Lille, France, 59020